References
- 金궤要略註釋 v.1 李克光
- 標準臨床方劑學 v.3 裵秉哲
- 本草學 全國韓醫科大學 本草學敎室
- 최신치료위암 v.1 徐滿正
- 이우주의 약리학강의 v.1 홍사석
- Cancer Res. v.61 Attenuation of Doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart Sun, X.;Zhou, Z.;Kang, Y.J.
- Oncol. v.19 The anthracyclines: will we ever find a better Doxorubicin Semin Weiss, R.B.
- Cancer v.60 Acute arrhythmogenicity of Doxorubicin administration Steinberg, J.S.;Cohen, A.J.;Wasserman, A.G.;Cohen, P.;Ross, A.M.
- J. Am. Med. Assoc. v.266 Cardiac toxicity 4 to 20 years after completing anthracycline therapy Steinherz, L.J.;Steinherz, P.G.;Tan, C.T.;Heller, G.;Murphy, M.L.
- HPMA copolymer-Doxorubicin( PK1). Hum. Exp. Toxicol. v.17 Preclinical toxicology of a novekl polymeric antitumour agent Duncan,R;Coatsworth, J.K;Burtles, S
- 암, 동서의학결합치료2 v.1 문구;정병학;김병주
- 傷寒論解釋 v.1 최달영;김준기
- 해리슨내과학 v.13 해리슨 내과학 편찬위원회
- Blood v.91 The tetrapeptide acetyl-N-Ser-Aso-Lys-Pro(Goralatide) protects from Doxorubicin-induced toxicity:improvment in mice survival and protection of bone marrow stem cells and progenitors Masse, A.;Ramirez, L.H.;Bindoula, G.;Grillon, C.;Wdzieczalk-Bakala, J.;Raddassi, K.(et al.)
- Crit. Rev. Oncol. Hematol. v.37 Caelyx(stealyh lipomal Doxorubicin) in the treatment of advanced breast cancer Ranson, M.R.;Cheeseman, S.;White, S.;Maqrigison, J.
- Anticancer Drugs v.11 The exo vivo effect of high concentration of Doxorubicin on recurrent ovarian carcinoma Neale, M.H.;Lamont, A.;Hindley, A.;Kurbacher, C.M.;Cree, I.A.
- Ann. Intern. Med. v.91 Risk factors for Doxorubicin-induced congestive heart failure Von Hoff, D.D.;Layard, M.W.;Basa, P.;Davis, H.L.Jr.;Von Hoff, A.L;Rozencweig, M.(et al.)
- Pharmacol. Res. v.43 The preventive role of deferoxamine against acute Doxorubicin-induced cardiac, renal and hepatic toxicity in rats Saad, S.Y.;Najjar, T.A.;Al-Rikabi, A.C.
- 大韓本草學會誌 v.14 no.2 半夏瀉心湯이 CCL4로 유도된 간중독 흰쥐에 미치는 영향 朱旺錫;朴賢俊;尹炳局;鄭成伊;朴宣東
- 방제학 v.2 李尙仁;金東傑;金永板;盧昇鉉;朴宣東;李暎鍾;周榮丞
- Cancer Chemother. Pharmacol. v.45 Comparison of the protective effects of amifostine and dexarazoxane against the toxicity of Doxorubicin in spontaneously hypertensive rats Herman, E.H.;Zhang, J.;Chadwick, D.P.;Ferrans, V.J.
- Eur. J. Cancer Clin. Oncol. v.23 Exogenous Doxorubicinol induces cardiotoxic effects in the rats Danesi, R.;de Tacca, M.;Bernardini, C.;Penco, S.
- Pharmacol. Toxicol. v.88 Role of daunorubicinol in daunorubicin-induced cardiotoxicity as evaluted with the model of isolated perfusedm rat heart Platel, D.;Bonoron-Adele, S.;Robert, J.
- Eur. J. Cancer v.37 Modification of Doxorubicin-induced cardiotoxicity;effect of essential fatty acids and ICRF-187(dexrazoxane) Chakrabrati, K.B.;Hpewell, J.W.;Wilding, D.;Plowman, P.N.
- J. Exp. Clin. Cancer Res. v.20 Chemopreventive effect of Ginkgo biloba extract against benzo(a) pyrene-induced forestomach carcinogenesis in mice:amelioration of Doxorubicin cardiotoxicity Agha, A.M.;El-Fattah, A.A.;Al-Zuhair, H.H.;Al-Rikabi, A.C.
- Cancer Chemother. Pharmacol. v.7 PNU159548, a novel cytotoxic antitumor agent with a low cardiotoxic potential Della Torre, P.;Podesta, A.;Imondi, A.R.;Moneta, D.;Sammartini, U.;Arrigoni, C.(et al.)
- Am. J. Physiol. Regul. Integr. Com. Physiol. A novel pharmacological action of ET-1 to prevent the cytotoxicity of Doxorubicin in cardiomyocytes Suzuki, T.;Miyauchi, T.
- Anticancer Res. v.18 Doxorubicin cardiotoxicity and serum lipid increase is prevented by dextrazoxane(ICRF-187) Samelis, G.F.;Stathopoulos, G.P.;Kotsarelis, D.;Dontas, I.;Frangia, C.;Karayannacos, P.E.
- Zhongguo Yao Li Xue Bao v.17 Effects of beta-carotene on Doxorubicin-induced cardiotoxicity in rats Lu, H.Z.;Geng, B.Q.;Zhu, Y.L.;Yong, D.G.
- Eur. J. Pharmacol. v.414 Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on Doxorubicin-induced cardiotoxicity in the rat Sacco, G.;Bigioni, M.;Ecangelista, S.;Goso, C.;Manzini, S.;Maggi, C.A.